Application 210655
- Type
- NDA
- Sponsor
- INDIVIOR INC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | PERSERIS KIT | RISPERIDONE | FOR SUSPENSION, EXTENDED RELEASE;SUBCUTANEOUS | 90MG | Yes | No |
| 002 | PERSERIS KIT | RISPERIDONE | FOR SUSPENSION, EXTENDED RELEASE;SUBCUTANEOUS | 120MG | Yes | Yes |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N210655-001 | PERSERIS KIT | RISPERIDONE | 90MG | FOR SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS | RLD | 2018-07-27 | |
| N210655-002 | PERSERIS KIT | RISPERIDONE | 120MG | FOR SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS | RLD | 2018-07-27 |
Orange Book patents#
| Application-product | Patent | Expiration | Use code | Coverage / status | Submission date |
|---|---|---|---|---|---|
| N210655-001 | 10406160 | 2026-06-26 | U-2608 | Drug product | 2019-09-26 |
| N210655-001 | 10058554 | 2026-09-26 | U-2363 | 2018-08-28 | |
| N210655-001 | 9597402 | 2026-09-26 | Drug product | 2018-07-31 | |
| N210655-001 | 11110093 | 2026-11-05 | U-3135 | Drug product | 2021-09-07 |
| N210655-001 | 10010612 | 2028-02-13 | Drug product | 2018-07-31 | |
| N210655-001 | 10376590 | 2028-02-13 | U-2608 | 2019-08-29 | |
| N210655-001 | 11013809 | 2028-02-13 | U-3135 | Drug product | 2021-07-01 |
| N210655-001 | 11712475 | 2028-02-13 | U-3135 | 2023-08-31 | |
| N210655-001 | 9180197 | 2028-02-13 | Drug product | 2018-07-31 | |
| N210655-001 | 9186413 | 2028-02-13 | U-543 | 2018-07-31 | |
| N210655-002 | 10406160 | 2026-06-26 | U-2608 | Drug product | 2019-09-26 |
| N210655-002 | 10058554 | 2026-09-26 | U-2363 | 2018-08-28 | |
| N210655-002 | 9597402 | 2026-09-26 | Drug product | 2018-07-31 | |
| N210655-002 | 11110093 | 2026-11-05 | U-3135 | Drug product | 2021-09-07 |
| N210655-002 | 10010612 | 2028-02-13 | Drug product | 2018-07-31 | |
| N210655-002 | 10376590 | 2028-02-13 | U-2608 | 2019-08-29 | |
| N210655-002 | 11013809 | 2028-02-13 | U-3135 | Drug product | 2021-07-01 |
| N210655-002 | 11712475 | 2028-02-13 | U-3135 | 2023-08-31 | |
| N210655-002 | 9180197 | 2028-02-13 | Drug product | 2018-07-31 | |
| N210655-002 | 9186413 | 2028-02-13 | U-543 | 2018-07-31 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N210655-001 | PERSERIS KIT | 90MG | FOR SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS | RLD | 2018-07-27 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N210655-002 | PERSERIS KIT | 120MG | FOR SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS | RLD | 2018-07-27 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | N210655-001 | PERSERIS KIT | 90MG | FOR SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS | RLD | 2018-07-27 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N210655-002 | PERSERIS KIT | 120MG | FOR SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS | RLD | 2018-07-27 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N210655-001 | PERSERIS KIT | 90MG | FOR SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS | RLD | 2018-07-27 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N210655-002 | PERSERIS KIT | 120MG | FOR SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS | RLD, RS | 2018-07-27 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N210655-001 | PERSERIS KIT | 90MG | FOR SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS | RLD | 2018-07-27 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N210655-002 | PERSERIS KIT | 120MG | FOR SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS | RLD, RS | 2018-07-27 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N210655-001 | PERSERIS KIT | 90MG | FOR SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS | RLD | 2018-07-27 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N210655-002 | PERSERIS KIT | 120MG | FOR SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS | RLD, RS | 2018-07-27 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N210655-001 | PERSERIS KIT | 90MG | FOR SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS | RLD | 2018-07-27 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N210655-002 | PERSERIS KIT | 120MG | FOR SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS | RLD, RS | 2018-07-27 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N210655-001 | PERSERIS KIT | 90MG | FOR SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS | RLD | 2018-07-27 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N210655-002 | PERSERIS KIT | 120MG | FOR SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS | RLD, RS | 2018-07-27 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N210655-001 | PERSERIS KIT | 90MG | FOR SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS | RLD | 2018-07-27 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N210655-002 | PERSERIS KIT | 120MG | FOR SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS | RLD, RS | 2018-07-27 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N210655-001 | PERSERIS KIT | 90MG | FOR SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS | RLD | 2018-07-27 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N210655-002 | PERSERIS KIT | 120MG | FOR SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS | RLD, RS | 2018-07-27 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N210655-001 | PERSERIS KIT | 90MG | FOR SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS | RLD | 2018-07-27 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N210655-002 | PERSERIS KIT | 120MG | FOR SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS | RLD, RS | 2018-07-27 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N210655-001 | PERSERIS KIT | 90MG | FOR SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS | RLD | 2018-07-27 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N210655-002 | PERSERIS KIT | 120MG | FOR SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS | RLD, RS | 2018-07-27 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N210655-001 | PERSERIS KIT | 90MG | FOR SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS | RLD | 2018-07-27 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | N210655-002 | PERSERIS KIT | 120MG | FOR SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS | RLD, RS | 2018-07-27 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N210655-001 | PERSERIS KIT | 90MG | FOR SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS | RLD | 2018-07-27 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N210655-002 | PERSERIS KIT | 120MG | FOR SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS | RLD, RS | 2018-07-27 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N210655-001 | PERSERIS KIT | 90MG | FOR SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS | RLD | 2018-07-27 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N210655-002 | PERSERIS KIT | 120MG | FOR SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS | RLD, RS | 2018-07-27 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N210655-001 | PERSERIS KIT | 90MG | FOR SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS | RLD | 2018-07-27 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N210655-002 | PERSERIS KIT | 120MG | FOR SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS | RLD, RS | 2018-07-27 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | N210655-001 | PERSERIS KIT | 90MG | FOR SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS | RLD | 2018-07-27 | 8072bd15b7f6… | |
| 2024-05-31 18:47 UTC | 2024-05 | N210655-002 | PERSERIS KIT | 120MG | FOR SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS | RLD, RS | 2018-07-27 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N210655-001 | PERSERIS KIT | 90MG | FOR SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS | RLD | 2018-07-27 | 5c6f7cd8ea54… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N210655-002 | PERSERIS KIT | 120MG | FOR SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS | RLD, RS | 2018-07-27 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | N210655-001 | PERSERIS KIT | 90MG | FOR SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS | RLD | 2018-07-27 | 5d02ea3f76ae… | |
| 2022-04-08 23:34 UTC | 2022-04 | N210655-002 | PERSERIS KIT | 120MG | FOR SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS | RLD, RS | 2018-07-27 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | N210655-001 | PERSERIS KIT | 90MG | FOR SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS | RLD | 2018-07-27 | 4b0b4de00fa7… | |
| 2022-04-04 05:41 UTC | 2022-04 | N210655-002 | PERSERIS KIT | 120MG | FOR SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS | RLD, RS | 2018-07-27 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | N210655-001 | PERSERIS KIT | 90MG | FOR SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS | RLD | 2018-07-27 | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | N210655-002 | PERSERIS KIT | 120MG | FOR SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS | RLD, RS | 2018-07-27 | 74a2ff9319b5… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N210655-001 | 10406160 | 2026-06-26 | U-2608 | Drug product | 2019-09-26 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N210655-001 | 10058554 | 2026-09-26 | U-2363 | 2018-08-28 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N210655-001 | 9597402 | 2026-09-26 | Drug product | 2018-07-31 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N210655-001 | 11110093 | 2026-11-05 | U-3135 | Drug product | 2021-09-07 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N210655-001 | 10010612 | 2028-02-13 | Drug product | 2018-07-31 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N210655-001 | 10376590 | 2028-02-13 | U-2608 | 2019-08-29 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N210655-001 | 11013809 | 2028-02-13 | U-3135 | Drug product | 2021-07-01 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N210655-001 | 11712475 | 2028-02-13 | U-3135 | 2023-08-31 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N210655-001 | 9180197 | 2028-02-13 | Drug product | 2018-07-31 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N210655-001 | 9186413 | 2028-02-13 | U-543 | 2018-07-31 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N210655-002 | 10406160 | 2026-06-26 | U-2608 | Drug product | 2019-09-26 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N210655-002 | 10058554 | 2026-09-26 | U-2363 | 2018-08-28 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N210655-002 | 9597402 | 2026-09-26 | Drug product | 2018-07-31 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N210655-002 | 11110093 | 2026-11-05 | U-3135 | Drug product | 2021-09-07 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N210655-002 | 10010612 | 2028-02-13 | Drug product | 2018-07-31 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N210655-002 | 10376590 | 2028-02-13 | U-2608 | 2019-08-29 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N210655-002 | 11013809 | 2028-02-13 | U-3135 | Drug product | 2021-07-01 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N210655-002 | 11712475 | 2028-02-13 | U-3135 | 2023-08-31 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N210655-002 | 9180197 | 2028-02-13 | Drug product | 2018-07-31 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N210655-002 | 9186413 | 2028-02-13 | U-543 | 2018-07-31 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | N210655-001 | 10406160 | 2026-06-26 | U-2608 | Drug product | 2019-09-26 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N210655-001 | 10058554 | 2026-09-26 | U-2363 | 2018-08-28 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N210655-001 | 9597402 | 2026-09-26 | Drug product | 2018-07-31 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N210655-001 | 11110093 | 2026-11-05 | U-3135 | Drug product | 2021-09-07 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N210655-001 | 10010612 | 2028-02-13 | Drug product | 2018-07-31 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N210655-001 | 10376590 | 2028-02-13 | U-2608 | 2019-08-29 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N210655-001 | 11013809 | 2028-02-13 | U-3135 | Drug product | 2021-07-01 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N210655-001 | 11712475 | 2028-02-13 | U-3135 | 2023-08-31 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N210655-001 | 9180197 | 2028-02-13 | Drug product | 2018-07-31 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N210655-001 | 9186413 | 2028-02-13 | U-543 | 2018-07-31 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N210655-002 | 10406160 | 2026-06-26 | U-2608 | Drug product | 2019-09-26 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N210655-002 | 10058554 | 2026-09-26 | U-2363 | 2018-08-28 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N210655-002 | 9597402 | 2026-09-26 | Drug product | 2018-07-31 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N210655-002 | 11110093 | 2026-11-05 | U-3135 | Drug product | 2021-09-07 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N210655-002 | 10010612 | 2028-02-13 | Drug product | 2018-07-31 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N210655-002 | 10376590 | 2028-02-13 | U-2608 | 2019-08-29 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N210655-002 | 11013809 | 2028-02-13 | U-3135 | Drug product | 2021-07-01 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N210655-002 | 11712475 | 2028-02-13 | U-3135 | 2023-08-31 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N210655-002 | 9180197 | 2028-02-13 | Drug product | 2018-07-31 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N210655-002 | 9186413 | 2028-02-13 | U-543 | 2018-07-31 | caaa826d4ba7… |
Observed Orange Book exclusivity history#
| Captured | Edition | Application-product | Exclusivity code | Expiration | Source SHA-256 |
|---|---|---|---|---|---|
| 2019-12-13 00:20 UTC | 2019-12 | N210655-001 | NP | 2021-07-27 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | N210655-002 | NP | 2021-07-27 | 74a2ff9319b5… |
| 2021-12-28 21:50 UTC | 2021-12 | N210655-001 | NP | 2021-07-27 | 782e0a99824c… |
| 2021-12-28 21:50 UTC | 2021-12 | N210655-002 | NP | 2021-07-27 | 782e0a99824c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N210655-001 | NP | 2021-07-27 | 87673890dc5c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N210655-002 | NP | 2021-07-27 | 87673890dc5c… |
| 2021-03-12 10:30 UTC | 2021-03 | N210655-001 | NP | 2021-07-27 | 5aa47cf7b7d7… |
| 2021-03-12 10:30 UTC | 2021-03 | N210655-002 | NP | 2021-07-27 | 5aa47cf7b7d7… |
| 2020-12-22 03:56 UTC | 2020-12 | N210655-001 | NP | 2021-07-27 | 8869cabd3fbd… |
| 2020-12-22 03:56 UTC | 2020-12 | N210655-002 | NP | 2021-07-27 | 8869cabd3fbd… |
| 2020-11-12 02:37 UTC | 2020-11 | N210655-001 | NP | 2021-07-27 | c0c555d07b60… |
| 2020-11-12 02:37 UTC | 2020-11 | N210655-002 | NP | 2021-07-27 | c0c555d07b60… |
| 2019-12-14 00:12 UTC | 2019-12 | N210655-001 | NP | 2021-07-27 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | N210655-002 | NP | 2021-07-27 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | N210655-001 | NP | 2021-07-27 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | N210655-002 | NP | 2021-07-27 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | N210655-001 | NP | 2021-07-27 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | N210655-002 | NP | 2021-07-27 | ea99ee380514… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| RISPERIDONE | RISPERIDONE | Chartwell RX, LLC | 66390528-7517-452a-ae76-4338ec7db3ae | 2023-10-06 | Boxed warning, Warnings, Adverse reactions | RISPERIDONE |
| Risperidone | RISPERIDONE | NCS HealthCare of KY, LLC dba Vangard Labs | 7bbc37f1-6d6a-4021-8976-1f103ce1cfbd | 2023-02-27 | Boxed warning, Warnings, Adverse reactions | RISPERIDONE |
| RISPERIDONE | RISPERIDONE | Aphena Pharma Solutions - Tennessee, LLC | bda104ac-1eea-4a1a-836a-24bcc034b90f | 2022-11-09 | Boxed warning, Warnings, Adverse reactions | RISPERIDONE |
| RISPERIDONE | RISPERIDONE | Proficient Rx LP | 2b9cce47-b8b3-4c9b-b26a-3d742a0db8e2 | 2022-10-01 | Boxed warning, Warnings, Adverse reactions | RISPERIDONE |
| RISPERIDONE | RISPERIDONE | Proficient Rx LP | 088dc3dd-7740-471b-8c06-5a47900ae5b5 | 2022-10-01 | Boxed warning, Warnings, Adverse reactions | RISPERIDONE |
| RISPERIDONE | RISPERIDONE | Proficient Rx LP | 1b5c9889-4dc3-48df-8629-4ac099e2b4c0 | 2022-10-01 | Boxed warning, Warnings, Adverse reactions | RISPERIDONE |
| Risperidone | RISPERIDONE | Sun Pharmaceutical Industries, Inc. | f91f551e-926f-440d-83d2-357e9d7484fe | 2022-07-13 | Boxed warning, Warnings, Adverse reactions | RISPERIDONE |
| RISPERIDONE | RISPERIDONE | Proficient Rx LP | 394c7e27-52a2-4d4c-8c6e-fe37b03266ae | 2022-06-01 | Boxed warning, Warnings, Adverse reactions | RISPERIDONE |
| risperidone | RISPERIDONE | Proficient Rx LP | b611fe52-1787-47e6-8a6b-1999a4e4f22c | 2021-01-01 | Boxed warning, Warnings, Adverse reactions | RISPERIDONE |
| RISPERIDONE | RISPERIDONE | Aphena Pharma Solutions - Tennessee, LLC | ac152803-d75f-4c3c-bc49-8663b21a3a82 | 2019-04-29 | Boxed warning, Warnings, Adverse reactions | RISPERIDONE |
| Risperidone | RISPERIDONE | Aphena Pharma Solutions - Tennessee, LLC | 58e422ec-da66-41b0-83c1-aefd940beda0 | 2019-04-10 | Boxed warning, Warnings, Adverse reactions | RISPERIDONE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 12496-0090 | PERSERIS | Risperidone | Indivior Inc. | NDA | Current |
| 12496-0090 | PERSERIS | Risperidone | Indivior Inc. | NDA | Current |
| 12496-0090 | PERSERIS | Risperidone | Indivior Inc. | NDA | Current |
| 12496-0090 | PERSERIS | Risperidone | Indivior Inc. | NDA | Current |
| 12496-0090 | PERSERIS | Risperidone | Indivior Inc. | NDA | Current |
| 12496-0090 | PERSERIS | Risperidone | Indivior Inc. | NDA | Current |
| 12496-0090 | PERSERIS | Risperidone | Indivior Inc. | NDA | Current |
| 12496-0090 | PERSERIS | Risperidone | Indivior Inc. | NDA | Current |
| 12496-0120 | PERSERIS | Risperidone | Indivior Inc. | NDA | Current |
| 12496-0120 | PERSERIS | Risperidone | Indivior Inc. | NDA | Current |
| 12496-0120 | PERSERIS | Risperidone | Indivior Inc. | NDA | Current |
| 12496-0120 | PERSERIS | Risperidone | Indivior Inc. | NDA | Current |
| 12496-0120 | PERSERIS | Risperidone | Indivior Inc. | NDA | Current |
| 12496-0120 | PERSERIS | Risperidone | Indivior Inc. | NDA | Current |
| 12496-0120 | PERSERIS | Risperidone | Indivior Inc. | NDA | Current |
| 12496-0120 | PERSERIS | Risperidone | Indivior Inc. | NDA | Current |